EMAIL THIS PAGE TO A FRIEND

Autophagy

Burkholderia pseudomallei survival in lung epithelial cells benefits from miRNA-mediated suppression of ATG10.


PMID 26151773

Abstract

Burkholderia pseudomallei is the causative agent of melioidosis, a disease with high mortality, which is prevalent in tropical regions of the world. A recent study shows that B. pseudomallei can survive inside mammalian cells because of its ability to actively evade cell autophagy. However, the underlying mechanisms remain unclear. In the present study, based on microarray screening, we found that ATG10 was downregulated following B. pseudomallei infection in A549 human lung epithelial cells. Forced expression of ATG10 accelerated the elimination of intracellular B. pseudomallei by enhancing the process of autophagy. Moreover, MIR4458, MIR4667-5p, and MIR4668-5p were found, by microarray screening, to be upregulated in response to B. pseudomallei infection. These 3 novel miRNAs, MIR4458, MIR4667-5p, and MIR4668-5p, targeted to the 3'-untranslated region of ATG10 in different time-course and spatial manners. Upregulation of these miRNAs reduced the level of ATG10 and inhibited autophagy, leading to increasing survival rate of intracellular B. pseudomallei. Furthermore, the increase of these miRNAs was correlated with the reduced promoter methylation status in A549 cells in response to B. pseudomallei infection. Our results reveal that 3 novel miRNAs regulate autophagy-mediated elimination of B. pseudomallei by targeting ATG10, and provide potential targets for clinical treatment.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A9356
Anti-ATG10 antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
A9482
Anti-ATG4C antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody, buffered aqueous solution
A0731
Anti-ATG5 (C-terminal) antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody
HPA018036
Anti-DRAM2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4200361
Anti-LC3B antibody, Mouse monoclonal, clone LC3B-6, purified from hybridoma cell culture
SAB2700738
Anti-Map1lc3b antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB3501065
Anti-MAP1LC3B antibody produced in rabbit, affinity isolated antibody
WH0081631M1
Monoclonal Anti-MAP1LC3B antibody produced in mouse, clone 4E11, purified immunoglobulin, buffered aqueous solution
SAB1405293
Monoclonal Anti-MAP1LC3B antibody produced in mouse, clone 4G7, purified immunoglobulin, buffered aqueous solution
R8781 Rapamycin, Ready Made Solution, 2.5 mg/mL in DMSO (2.74 mM), from Streptomyces hygroscopicus
C51H79NO13
688770
tert-Butyl acetoacetate, Lonza quality, ≥98.0% (w/w) (GC)
C8H14O3
10911
tert-Butyl acetoacetate, produced by Wacker Chemie AG, Burghausen, Germany, ≥98.0% (GC)
C8H14O3
537594
tert-Butyl acetoacetate, reagent grade, 98%
C8H14O3
B88608
tert-Butyl acetoacetate, reagent grade, 97%
C8H14O3
T8787
Triton X-100, for molecular biology
P1379
TWEEN® 20, viscous liquid